Determinants of Cognitive Impairment Among Geriatrics

Sponsor
Faculty of Medicine, Tarumanagara University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03669536
Collaborator
Hana Old Age Home (Other)
80
1
16
5

Study Details

Study Description

Brief Summary

This study aims to explore the determinants of cognitive impairment among Indonesian geriatrics in an Old Age Home.

Detailed Description

Elderly patients (≥ 60 years of age) are enrolled in this study. The inclusion criteria are patients which have consented to take part in the study.

Data such as age, ethnic, education, BMI, waist and hip circumference, blood pressure, hearing impairment, vision impairment, depression, sleep disorder, mobility, hemoglobin levels, glycemic and lipid profile, as well as comorbidities and drugs used were collected from the patients' medical records, laboratory tests and through examination by trained examiners.

Cognition was determined through a combination of several psychiatric examinations using validated instruments namely - MiniCog, Clock Drawing Test, Three Word Recall, Alzheimer's Disease-8 Indonesia (AD-8 INA) Questionnaire and Short Portable Mental Status Questionnaire (SPMSQ).

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Observational Model:
Ecologic or Community
Time Perspective:
Cross-Sectional
Official Title:
Determinants of Cognitive Impairment Among Geriatrics in an Indonesian Old Age Home
Actual Study Start Date :
Aug 1, 2017
Anticipated Primary Completion Date :
Dec 1, 2018
Anticipated Study Completion Date :
Dec 1, 2018

Outcome Measures

Primary Outcome Measures

  1. MiniCog [Through study completion, an average of 6 months]

    Based on psychiatric examination using the Indonesian MiniCog Questionnaire to determine patient's cognitive status. A MiniCog result below 5 implies mild cognitive impairment, while a result below 3 implies dementia.

  2. Clock Drawing Test (CDT) [Through study completion, an average of 6 months]

    Based on psychiatric examination using the Indonesian Clock Drawing Test to determine patient's cognitive status. A Clock Drawing Test score below 4 implies mild cognitive impairment.

  3. Three Word Recall [Through study completion, an average of 6 months]

    Based on psychiatric examination using the Indonesian Three Word Recall Test to determine patient's cognitive status with resulting score from 0-3. Zero means no words can be recalled by the patient.

  4. Alzheimer Disease-8 Indonesia Questionnaire (AD-8 INA) [Through study completion, an average of 6 months]

    Based on interviews with caretakers using the AD-8 INA Questionnaire to determine patient's cognitive status. An AD-8 INA score of 2 or more implies mild cognitive impairment.

  5. Short Portable Mental Status Questionnaire (SPMSQ) [Through study completion, an average of 6 months]

    Based on psychiatric examination using the Indonesian SPMSQ to determine patient's cognitive status. An SPMSQ test in which the patient demonstrated more than 3 mistakes implies mild cognitive impairment, whereas a mistake of greater than 8 implies dementia.

Other Outcome Measures

  1. Hearing Impairment [Through study completion, an average of 6 months]

    Based on physical examination using the Whispered Sound Test from 6 meters and tuning fork test as well as history of hearing impairment from medical records.

  2. Vision Impairment [Through study completion, an average of 6 months]

    Based on physical examination using the Snellen Chart and history of vision impairment from medical records.

  3. Diabetes [Through study completion, an average of 6 months]

    Based on glycemic profile results and history of diabetes from medical records. Patients are classified as diabetic in accordance to the Indonesian Society of Endocrinology and American Diabetic Association criteria.

  4. Mobility [Through study completion, an average of 6 months]

    Based on physical examination, Indonesian Validated Lequesne Index, Barthel Acitivities of Daily Living (ADL), Instrumental ADL and history of arthritis or other pathologies affecting mobility from medical records.

  5. Depression [Through study completion, an average of 6 months]

    Based on psychiatric examination, Indonesian Validated Geriatric Depression Scale and Medical Records. A score of 5-9 implies a likelihood of depression, while a score of greater than 10 implies depression.

  6. Sleep Disorder [Through study completion, an average of 6 months]

    Based on psychiatric examination, Indonesian Validated Insomnia Severity Index and Medical Records. A score of 8-14 implies mild insomnia, 15-21 intermediate insomnia and 22-28 severe insomnia.

  7. Hypertension [Through study completion, an average of 6 months]

    Based on blood pressure results and history of hypertension from medical records.

  8. Dyslipidemia [Through study completion, an average of 6 months]

    Based on lipid profile results and history of dyslipidemia from medical records.

  9. Anemia [Through study completion, an average of 6 months]

    Based on hemoglobin results.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Must be classified as geriatric according to Indonesian Laws (≥ 60 years of age).

  • Consented to participate in this study.

Exclusion Criteria:
  • Uncooperative.

  • Incomplete records.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hana Old Age Home Tangerang Banten Indonesia 15415

Sponsors and Collaborators

  • Faculty of Medicine, Tarumanagara University
  • Hana Old Age Home

Investigators

  • Principal Investigator: Anthony P Sunjaya, Faculty of Medicine, Tarumanagara University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anthony Paulo Sunjaya, Principal Investigator, Faculty of Medicine, Tarumanagara University
ClinicalTrials.gov Identifier:
NCT03669536
Other Study ID Numbers:
  • APS007
First Posted:
Sep 13, 2018
Last Update Posted:
Sep 13, 2018
Last Verified:
Sep 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Anthony Paulo Sunjaya, Principal Investigator, Faculty of Medicine, Tarumanagara University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2018